Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,038 public trials 1,176 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment

NCT01232296

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Novartis Investigative Site Nanjing, Jiangsu, China

Novartis Investigative Site Xi’an, Shanxi, China

Novartis Investigative Site Hangzhou, Zhejiang, China

Novartis Investigative Site Beijing, China

View all 24 locations

View Trial Details

Completed

to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)

NCT02008929

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

NCT00625456

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
Locations: Billings Clinic Billings, Montana, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Cancer Centers of the Carolinas Greenville, South Carolina, United States

Ottawa Health Research Institute Ottawa, Ontario, Canada

View Trial Details

Completed

Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

NCT00807300

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Clinic of Diagnostic Radiology and Nuclear Medicine, Medical Faculty, University Magdeburg Magdeburg, Saxony-Anhalt, Germany

View Trial Details

Completed

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

NCT00694096

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

NCT00459875

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver

NCT01474694

Conditions: Adenocarcinoma, Adult Liver Cancer, Carcinoma, +9 more
Locations: Dep. of visceral and Transplant Surgery, Bern University Hospital Bern, Switzerland

View Trial Details

Completed

Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

NCT01506115

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Samsung Medical Center 81 Irwon-Ro Gangnamgu Seoul, South Korea

View Trial Details

Completed

Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)

NCT01122615

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions